A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).

Condition:   Neovascular Age-related Macular Degeneration Intervention:   Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials